FDA approves aspheric AcrySof IQ toric IOL

Alcon Labs has recently announced that the U.S. Food and Drug Administration has approved Alcon's aspheric AcrySof IQ toric IOL for use in cataract surgery patients with astigmatism.  The new AcrySof toric lens has an enhanced aspheric optic for improved image quality, increased contrast sensitivity and quality distance vision without spectacle correction,

The first AcrySof® Toric lens was introduced in 2005 and quickly became the leading toric lens on the market, due to its predictable power outcomes and excellent rotational stability. These benefits are largely realized due to the strengths of the AcrySof® IOL material and proprietary single-piece design. 

I have gotten superb results in implanting this lens in my cataract patients with astigmatism.  These patients are able to attain incredible distance vision without the need for glasses or contacts!  I expect this new modification to furhter improve my patients ability to see clearly, especially in low contrast situations such as night driving.

Comments

[David D. Richardson, MD]

I have also had positive results with the AcrySof Toric platform and am looking forward to using the new higher toric powers.

[Cary Silverman]

I agree,higher toric powers will be very beneficial to those patients with higher amounts of pre op astigmatism!

[e cigarettes]

I am beginning to really lose all faith and credibility in the FDA. It seems to me that instead of focusing their efforts on protecting the general public they are in-turn being influenced by corporate agenda and special interest. I take everything they say with a grain of salt.